CStone and LegoChem Biosciences Enter Global Licensing Agreeme...
- Written by LATEST ASIANET NEWS RELEASES
- Published in Asia Net
SUZHOU, China, Oct. 29, 2020 /PRNewswire-Asianet/ -- -CStone to acquire exclusive rights for development and commercialization outside South Korea for LCB71, an ROR1 antibody drug conjugate -Agreement adds to CStone's pipeline a potential first-in-class/best-in-class drug candidate with monotherap...
Authors: LATEST ASIANET NEWS RELEASES